{"id":54263,"date":"2021-12-22T09:57:55","date_gmt":"2021-12-22T14:57:55","guid":{"rendered":"https:\/\/regstaging.wpengine.com\/fda-will-continue-unannounced-inspections-in-2022\/"},"modified":"2022-01-07T16:36:20","modified_gmt":"2022-01-07T21:36:20","slug":"fda-will-continue-unannounced-inspections-in-2022","status":"publish","type":"post","link":"https:\/\/legacy.registrarcorp.com\/pt\/fda-will-continue-unannounced-inspections-in-2022\/","title":{"rendered":"A FDA Continuar\u00e1 as Inspe\u00e7\u00f5es n\u00e3o anunciadas Em 2022"},"content":{"rendered":"<p>A Administra\u00e7\u00e3o de Alimentos e Medicamentos (FDA) dos Estados Unidos retomar\u00e1 um programa piloto que levar\u00e1 a inspe\u00e7\u00f5es \u201c<em>in loco <\/em>\u201d n\u00e3o anunciadas na \u00cdndia e na China. A FDA pretende iniciar as inspe\u00e7\u00f5es no in\u00edcio de 2022.<\/p>\n<p>Elizabeth Miller, do Escrit\u00f3rio Assuntos Regulat\u00f3rios (ORA) da FDA, anunciou as pr\u00f3ximas inspe\u00e7\u00f5es durante uma confer\u00eancia virtual organizada pelo o Instituto Legal de Alimentos e Medicamentos em 9 de dezembro de 2021.<\/p>\n<div class=\"callout-row text-center margin-bottom\">\n<h3>Perguntas sobre as inspe\u00e7\u00f5es da FDA?<\/h3>\n<p>A Registrar Corp pode ajud\u00e1-lo a se preparar para uma inspe\u00e7\u00e3o da FDA. Para obter mais informa\u00e7\u00f5es, ligue para + 1-757-224-0177, envie um e-mail para <a href=\"mailto:info@registrarcorp.com\">info@registrarcorp.com<\/a> ou fale com um consultor regulat\u00f3rio 24 horas por dia em <a href=\"https:\/\/regstaging.wpengine.com\/livechat\">regstaging.wpengine.com\/livechat<\/a>.<\/p>\n<p class=\"btn-row\"><a class=\"btn btn-red-white\" href=\"https:\/\/regstaging.wpengine.com\/pt\/livechat\/\">Converse Conosco Agora<\/a><\/p>\n<\/div>\n<p>Continue lendo sobre o programa piloto de inspe\u00e7\u00e3o da FDA e outros planos de inspe\u00e7\u00e3o.<\/p>\n<p><strong>Programa Piloto de Inspe\u00e7\u00f5es da FDA<\/strong><\/p>\n<p>Em 13 de julho de 2020, o Comit\u00ea or\u00e7ament\u00e1rio da C\u00e2mara divulgou um relat\u00f3rio que, entre outras coisas, abordou o crescimento das instala\u00e7\u00f5es de fabrica\u00e7\u00e3o de medicamentos supervisionadas, afirmando que as pr\u00e1ticas de inspe\u00e7\u00e3o da FDA n\u00e3o seguiram o ritmo de crescimento da ind\u00fastria global. O relat\u00f3rio tamb\u00e9m apontou para a disparidade entre as inspe\u00e7\u00f5es nos Estados Unidos e fora dos Estados Unidos.<\/p>\n<p>O Comit\u00ea fez refer\u00eancia ao programa piloto do FDA em 2014 na \u00cdndia, que implementou inspe\u00e7\u00f5es n\u00e3o anunciadas. O relat\u00f3rio instruiu a FDA a reiniciar o piloto, que havia sido descontinuado em 2015. O comit\u00ea tamb\u00e9m instruiu o FDA a criar um piloto adicional na China.<\/p>\n<p><strong>Outras Not\u00edcias de Inspe\u00e7\u00f5es<\/strong><\/p>\n<p>Junto com os programas-piloto na \u00cdndia e na China, a FDA ajustou os procedimentos de inspe\u00e7\u00e3o para lidar com inspe\u00e7\u00f5es atrasadas. O atraso nas inspe\u00e7\u00f5es da FDA ocorreu por causa da pandemia de COVID-19.<\/p>\n<p>Embora as restri\u00e7\u00f5es de viagens tenham atrasado as inspe\u00e7\u00f5es priorizadas por certos supervisores, a FDA planeja retomar essas inspe\u00e7\u00f5es a partir de fevereiro de 2022. As inspe\u00e7\u00f5es priorit\u00e1rias, geralmente anunciadas, s\u00e3o para produtos usados para tratar doen\u00e7as ou condi\u00e7\u00f5es graves ou para produtos relacionados a um evento adverso s\u00e9rio ou relacionado a um surto de doen\u00e7as transmitidas por alimentos.<\/p>\n<p>A FDA tamb\u00e9m planeja continuar usando uma abordagem h\u00edbrida para conduzir as inspe\u00e7\u00f5es. Durante a pandemia, a FDA exigiu que as instala\u00e7\u00f5es apresentassem relat\u00f3rios antes das inspe\u00e7\u00f5es <em>\u201cIn Loco\u201d<\/em>. Miller informou \u00e0 confer\u00eancia que este modelo h\u00edbrido provavelmente se tornar\u00e1 comum.<\/p>\n<div class=\"callout-row text-center margin-bottom\">\n<h3>Perguntas sobre as inspe\u00e7\u00f5es da FDA?<\/h3>\n<p>A Registrar Corp pode ajud\u00e1-lo a se preparar para uma inspe\u00e7\u00e3o da FDA. Para obter mais informa\u00e7\u00f5es, ligue para + 1-757-224-0177, envie um e-mail para <a href=\"mailto:info@registrarcorp.com\">info@registrarcorp.com<\/a> ou fale com um consultor regulat\u00f3rio 24 horas por dia em <a href=\"https:\/\/regstaging.wpengine.com\/livechat\">regstaging.wpengine.com\/livechat<\/a>.<\/p>\n<p class=\"btn-row\"><a class=\"btn btn-red-white\" href=\"https:\/\/regstaging.wpengine.com\/pt\/livechat\/\">Converse Conosco Agora<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>A Administra\u00e7\u00e3o de Alimentos e Medicamentos (FDA) dos Estados Unidos retomar\u00e1 um programa piloto que levar\u00e1 a inspe\u00e7\u00f5es \u201cin loco \u201d n\u00e3o anunciadas na \u00cdndia e na China. A FDA pretende iniciar as inspe\u00e7\u00f5es no in\u00edcio de 2022. Elizabeth Miller, do Escrit\u00f3rio Assuntos Regulat\u00f3rios (ORA) da FDA, anunciou as pr\u00f3ximas inspe\u00e7\u00f5es durante uma confer\u00eancia virtual<\/p>\n","protected":false},"author":30,"featured_media":54228,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"content-type":"","om_disable_all_campaigns":false,"inline_featured_image":false,"_genesis_hide_title":false,"_genesis_hide_breadcrumbs":false,"_genesis_hide_singular_image":false,"_genesis_hide_footer_widgets":false,"_genesis_custom_body_class":"","_genesis_custom_post_class":"","_genesis_layout":"","footnotes":""},"categories":[96],"tags":[],"class_list":{"0":"post-54263","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-drugs-pt","8":"entry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.9 (Yoast SEO v25.5) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>A FDA Continuar\u00e1 as Inspe\u00e7\u00f5es n\u00e3o anunciadas Em 2022 - Registrar<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"pt_PT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"A FDA Continuar\u00e1 as Inspe\u00e7\u00f5es n\u00e3o anunciadas Em 2022\" \/>\n<meta property=\"og:description\" content=\"A Administra\u00e7\u00e3o de Alimentos e Medicamentos (FDA) dos Estados Unidos retomar\u00e1 um programa piloto que levar\u00e1 a inspe\u00e7\u00f5es \u201cin loco \u201d n\u00e3o anunciadas na \u00cdndia e na China. A FDA pretende iniciar as inspe\u00e7\u00f5es no in\u00edcio de 2022. Elizabeth Miller, do Escrit\u00f3rio Assuntos Regulat\u00f3rios (ORA) da FDA, anunciou as pr\u00f3ximas inspe\u00e7\u00f5es durante uma confer\u00eancia virtual\" \/>\n<meta property=\"og:url\" content=\"https:\/\/legacy.registrarcorp.com\/pt\/fda-will-continue-unannounced-inspections-in-2022\/\" \/>\n<meta property=\"og:site_name\" content=\"Registrar\" \/>\n<meta property=\"article:published_time\" content=\"2021-12-22T14:57:55+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-01-07T21:36:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/legacy.registrarcorp.com\/wp-content\/uploads\/2021\/12\/technologist-industrial-worker-hazardous-suit-handling-aggressive-materials-chemical-industry-scaled-e1640185026108.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1709\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Mason Grandusky\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Mason Grandusky\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/legacy.registrarcorp.com\/pt\/fda-will-continue-unannounced-inspections-in-2022\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/legacy.registrarcorp.com\/pt\/fda-will-continue-unannounced-inspections-in-2022\/\"},\"author\":{\"name\":\"Mason Grandusky\",\"@id\":\"https:\/\/legacy.registrarcorp.com\/pt\/#\/schema\/person\/5460f453ed04f326b4ef5280009675f2\"},\"headline\":\"A FDA Continuar\u00e1 as Inspe\u00e7\u00f5es n\u00e3o anunciadas Em 2022\",\"datePublished\":\"2021-12-22T14:57:55+00:00\",\"dateModified\":\"2022-01-07T21:36:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/legacy.registrarcorp.com\/pt\/fda-will-continue-unannounced-inspections-in-2022\/\"},\"wordCount\":506,\"publisher\":{\"@id\":\"https:\/\/legacy.registrarcorp.com\/pt\/#organization\"},\"image\":{\"@id\":\"https:\/\/legacy.registrarcorp.com\/pt\/fda-will-continue-unannounced-inspections-in-2022\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/legacy.registrarcorp.com\/wp-content\/uploads\/2021\/12\/technologist-industrial-worker-hazardous-suit-handling-aggressive-materials-chemical-industry-scaled-e1640185026108.jpg\",\"articleSection\":[\"Medicamentos\"],\"inLanguage\":\"pt\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/legacy.registrarcorp.com\/pt\/fda-will-continue-unannounced-inspections-in-2022\/\",\"url\":\"https:\/\/legacy.registrarcorp.com\/pt\/fda-will-continue-unannounced-inspections-in-2022\/\",\"name\":\"A FDA Continuar\u00e1 as Inspe\u00e7\u00f5es n\u00e3o anunciadas Em 2022 - Registrar\",\"isPartOf\":{\"@id\":\"https:\/\/legacy.registrarcorp.com\/pt\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/legacy.registrarcorp.com\/pt\/fda-will-continue-unannounced-inspections-in-2022\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/legacy.registrarcorp.com\/pt\/fda-will-continue-unannounced-inspections-in-2022\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/legacy.registrarcorp.com\/wp-content\/uploads\/2021\/12\/technologist-industrial-worker-hazardous-suit-handling-aggressive-materials-chemical-industry-scaled-e1640185026108.jpg\",\"datePublished\":\"2021-12-22T14:57:55+00:00\",\"dateModified\":\"2022-01-07T21:36:20+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/legacy.registrarcorp.com\/pt\/fda-will-continue-unannounced-inspections-in-2022\/#breadcrumb\"},\"inLanguage\":\"pt\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/legacy.registrarcorp.com\/pt\/fda-will-continue-unannounced-inspections-in-2022\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt\",\"@id\":\"https:\/\/legacy.registrarcorp.com\/pt\/fda-will-continue-unannounced-inspections-in-2022\/#primaryimage\",\"url\":\"https:\/\/legacy.registrarcorp.com\/wp-content\/uploads\/2021\/12\/technologist-industrial-worker-hazardous-suit-handling-aggressive-materials-chemical-industry-scaled-e1640185026108.jpg\",\"contentUrl\":\"https:\/\/legacy.registrarcorp.com\/wp-content\/uploads\/2021\/12\/technologist-industrial-worker-hazardous-suit-handling-aggressive-materials-chemical-industry-scaled-e1640185026108.jpg\",\"width\":2560,\"height\":1709,\"caption\":\"Technologist industrial worker in hazardous suit handling aggressive materials in chemical industry.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/legacy.registrarcorp.com\/pt\/fda-will-continue-unannounced-inspections-in-2022\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/legacy.registrarcorp.com\/pt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"A FDA Continuar\u00e1 as Inspe\u00e7\u00f5es n\u00e3o anunciadas Em 2022\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/legacy.registrarcorp.com\/pt\/#website\",\"url\":\"https:\/\/legacy.registrarcorp.com\/pt\/\",\"name\":\"Registrar\",\"description\":\"Assistance with U.S. FDA Regulations\",\"publisher\":{\"@id\":\"https:\/\/legacy.registrarcorp.com\/pt\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/legacy.registrarcorp.com\/pt\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/legacy.registrarcorp.com\/pt\/#organization\",\"name\":\"Registrar Corp\",\"url\":\"https:\/\/legacy.registrarcorp.com\/pt\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt\",\"@id\":\"https:\/\/legacy.registrarcorp.com\/pt\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/legacy.registrarcorp.com\/wp-content\/uploads\/2019\/12\/regcorp_logo.png\",\"contentUrl\":\"https:\/\/legacy.registrarcorp.com\/wp-content\/uploads\/2019\/12\/regcorp_logo.png\",\"width\":1326,\"height\":330,\"caption\":\"Registrar Corp\"},\"image\":{\"@id\":\"https:\/\/legacy.registrarcorp.com\/pt\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/legacy.registrarcorp.com\/pt\/#\/schema\/person\/5460f453ed04f326b4ef5280009675f2\",\"name\":\"Mason Grandusky\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt\",\"@id\":\"https:\/\/legacy.registrarcorp.com\/pt\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/20ae894ac7fdae57b794f1b1792f9c9f1920bc809d0aab245d70e0aa7c997266?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/20ae894ac7fdae57b794f1b1792f9c9f1920bc809d0aab245d70e0aa7c997266?s=96&d=mm&r=g\",\"caption\":\"Mason Grandusky\"},\"url\":\"https:\/\/legacy.registrarcorp.com\/pt\/author\/mgrandusky\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"A FDA Continuar\u00e1 as Inspe\u00e7\u00f5es n\u00e3o anunciadas Em 2022 - Registrar","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"pt_PT","og_type":"article","og_title":"A FDA Continuar\u00e1 as Inspe\u00e7\u00f5es n\u00e3o anunciadas Em 2022","og_description":"A Administra\u00e7\u00e3o de Alimentos e Medicamentos (FDA) dos Estados Unidos retomar\u00e1 um programa piloto que levar\u00e1 a inspe\u00e7\u00f5es \u201cin loco \u201d n\u00e3o anunciadas na \u00cdndia e na China. A FDA pretende iniciar as inspe\u00e7\u00f5es no in\u00edcio de 2022. Elizabeth Miller, do Escrit\u00f3rio Assuntos Regulat\u00f3rios (ORA) da FDA, anunciou as pr\u00f3ximas inspe\u00e7\u00f5es durante uma confer\u00eancia virtual","og_url":"https:\/\/legacy.registrarcorp.com\/pt\/fda-will-continue-unannounced-inspections-in-2022\/","og_site_name":"Registrar","article_published_time":"2021-12-22T14:57:55+00:00","article_modified_time":"2022-01-07T21:36:20+00:00","og_image":[{"width":2560,"height":1709,"url":"https:\/\/legacy.registrarcorp.com\/wp-content\/uploads\/2021\/12\/technologist-industrial-worker-hazardous-suit-handling-aggressive-materials-chemical-industry-scaled-e1640185026108.jpg","type":"image\/jpeg"}],"author":"Mason Grandusky","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Mason Grandusky","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/legacy.registrarcorp.com\/pt\/fda-will-continue-unannounced-inspections-in-2022\/#article","isPartOf":{"@id":"https:\/\/legacy.registrarcorp.com\/pt\/fda-will-continue-unannounced-inspections-in-2022\/"},"author":{"name":"Mason Grandusky","@id":"https:\/\/legacy.registrarcorp.com\/pt\/#\/schema\/person\/5460f453ed04f326b4ef5280009675f2"},"headline":"A FDA Continuar\u00e1 as Inspe\u00e7\u00f5es n\u00e3o anunciadas Em 2022","datePublished":"2021-12-22T14:57:55+00:00","dateModified":"2022-01-07T21:36:20+00:00","mainEntityOfPage":{"@id":"https:\/\/legacy.registrarcorp.com\/pt\/fda-will-continue-unannounced-inspections-in-2022\/"},"wordCount":506,"publisher":{"@id":"https:\/\/legacy.registrarcorp.com\/pt\/#organization"},"image":{"@id":"https:\/\/legacy.registrarcorp.com\/pt\/fda-will-continue-unannounced-inspections-in-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/legacy.registrarcorp.com\/wp-content\/uploads\/2021\/12\/technologist-industrial-worker-hazardous-suit-handling-aggressive-materials-chemical-industry-scaled-e1640185026108.jpg","articleSection":["Medicamentos"],"inLanguage":"pt"},{"@type":"WebPage","@id":"https:\/\/legacy.registrarcorp.com\/pt\/fda-will-continue-unannounced-inspections-in-2022\/","url":"https:\/\/legacy.registrarcorp.com\/pt\/fda-will-continue-unannounced-inspections-in-2022\/","name":"A FDA Continuar\u00e1 as Inspe\u00e7\u00f5es n\u00e3o anunciadas Em 2022 - Registrar","isPartOf":{"@id":"https:\/\/legacy.registrarcorp.com\/pt\/#website"},"primaryImageOfPage":{"@id":"https:\/\/legacy.registrarcorp.com\/pt\/fda-will-continue-unannounced-inspections-in-2022\/#primaryimage"},"image":{"@id":"https:\/\/legacy.registrarcorp.com\/pt\/fda-will-continue-unannounced-inspections-in-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/legacy.registrarcorp.com\/wp-content\/uploads\/2021\/12\/technologist-industrial-worker-hazardous-suit-handling-aggressive-materials-chemical-industry-scaled-e1640185026108.jpg","datePublished":"2021-12-22T14:57:55+00:00","dateModified":"2022-01-07T21:36:20+00:00","breadcrumb":{"@id":"https:\/\/legacy.registrarcorp.com\/pt\/fda-will-continue-unannounced-inspections-in-2022\/#breadcrumb"},"inLanguage":"pt","potentialAction":[{"@type":"ReadAction","target":["https:\/\/legacy.registrarcorp.com\/pt\/fda-will-continue-unannounced-inspections-in-2022\/"]}]},{"@type":"ImageObject","inLanguage":"pt","@id":"https:\/\/legacy.registrarcorp.com\/pt\/fda-will-continue-unannounced-inspections-in-2022\/#primaryimage","url":"https:\/\/legacy.registrarcorp.com\/wp-content\/uploads\/2021\/12\/technologist-industrial-worker-hazardous-suit-handling-aggressive-materials-chemical-industry-scaled-e1640185026108.jpg","contentUrl":"https:\/\/legacy.registrarcorp.com\/wp-content\/uploads\/2021\/12\/technologist-industrial-worker-hazardous-suit-handling-aggressive-materials-chemical-industry-scaled-e1640185026108.jpg","width":2560,"height":1709,"caption":"Technologist industrial worker in hazardous suit handling aggressive materials in chemical industry."},{"@type":"BreadcrumbList","@id":"https:\/\/legacy.registrarcorp.com\/pt\/fda-will-continue-unannounced-inspections-in-2022\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/legacy.registrarcorp.com\/pt\/"},{"@type":"ListItem","position":2,"name":"A FDA Continuar\u00e1 as Inspe\u00e7\u00f5es n\u00e3o anunciadas Em 2022"}]},{"@type":"WebSite","@id":"https:\/\/legacy.registrarcorp.com\/pt\/#website","url":"https:\/\/legacy.registrarcorp.com\/pt\/","name":"Registrar","description":"Assistance with U.S. FDA Regulations","publisher":{"@id":"https:\/\/legacy.registrarcorp.com\/pt\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/legacy.registrarcorp.com\/pt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt"},{"@type":"Organization","@id":"https:\/\/legacy.registrarcorp.com\/pt\/#organization","name":"Registrar Corp","url":"https:\/\/legacy.registrarcorp.com\/pt\/","logo":{"@type":"ImageObject","inLanguage":"pt","@id":"https:\/\/legacy.registrarcorp.com\/pt\/#\/schema\/logo\/image\/","url":"https:\/\/legacy.registrarcorp.com\/wp-content\/uploads\/2019\/12\/regcorp_logo.png","contentUrl":"https:\/\/legacy.registrarcorp.com\/wp-content\/uploads\/2019\/12\/regcorp_logo.png","width":1326,"height":330,"caption":"Registrar Corp"},"image":{"@id":"https:\/\/legacy.registrarcorp.com\/pt\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/legacy.registrarcorp.com\/pt\/#\/schema\/person\/5460f453ed04f326b4ef5280009675f2","name":"Mason Grandusky","image":{"@type":"ImageObject","inLanguage":"pt","@id":"https:\/\/legacy.registrarcorp.com\/pt\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/20ae894ac7fdae57b794f1b1792f9c9f1920bc809d0aab245d70e0aa7c997266?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/20ae894ac7fdae57b794f1b1792f9c9f1920bc809d0aab245d70e0aa7c997266?s=96&d=mm&r=g","caption":"Mason Grandusky"},"url":"https:\/\/legacy.registrarcorp.com\/pt\/author\/mgrandusky\/"}]}},"_links":{"self":[{"href":"https:\/\/legacy.registrarcorp.com\/pt\/wp-json\/wp\/v2\/posts\/54263","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/legacy.registrarcorp.com\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/legacy.registrarcorp.com\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/legacy.registrarcorp.com\/pt\/wp-json\/wp\/v2\/users\/30"}],"replies":[{"embeddable":true,"href":"https:\/\/legacy.registrarcorp.com\/pt\/wp-json\/wp\/v2\/comments?post=54263"}],"version-history":[{"count":0,"href":"https:\/\/legacy.registrarcorp.com\/pt\/wp-json\/wp\/v2\/posts\/54263\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/legacy.registrarcorp.com\/pt\/wp-json\/wp\/v2\/media\/54228"}],"wp:attachment":[{"href":"https:\/\/legacy.registrarcorp.com\/pt\/wp-json\/wp\/v2\/media?parent=54263"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/legacy.registrarcorp.com\/pt\/wp-json\/wp\/v2\/categories?post=54263"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/legacy.registrarcorp.com\/pt\/wp-json\/wp\/v2\/tags?post=54263"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}